294 related articles for article (PubMed ID: 210352)
1. Pathophysiology of lipoprotein transport.
Brunzell JD; Chait A; Bierman EL
Metabolism; 1978 Sep; 27(9):1109-27. PubMed ID: 210352
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein apoprotein metabolism.
Schaefer EJ; Eisenberg S; Levy RI
J Lipid Res; 1978 Aug; 19(6):667-87. PubMed ID: 211170
[No Abstract] [Full Text] [Related]
3. Current status of the nosology of the hyperlipidemias.
Bilheimer DW
Birth Defects Orig Artic Ser; 1978; 14(6B):47-67. PubMed ID: 215244
[No Abstract] [Full Text] [Related]
4. Mechanisms of hyperlipoproteinemia.
Havel RJ
Adv Exp Med Biol; 1972; 26(0):57-70. PubMed ID: 4370189
[No Abstract] [Full Text] [Related]
5. The lipid hypothesis. Genetic basis.
Glueck CJ; Kwiterovich PO
Arch Surg; 1978 Jan; 113(1):35-41. PubMed ID: 202221
[No Abstract] [Full Text] [Related]
6. Xanthomatosis and hyperlipoproteinemia; a review.
Polano MK
Dermatologica; 1974; 149(1):1-9. PubMed ID: 4372111
[No Abstract] [Full Text] [Related]
7. Plasma lipoproteins: recent developments.
Gotto AM; Jackson RL
Adv Exp Med Biol; 1977; 82():15-33. PubMed ID: 200086
[No Abstract] [Full Text] [Related]
8. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
9. [Pathogenesis of hyperlipoproteinemias].
Müller G
Z Gesamte Inn Med; 1974 Jun; 29(12):469-76. PubMed ID: 4368206
[No Abstract] [Full Text] [Related]
10. Classification of lipoproteins and lipoprotein disorders.
Lewis B
J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():26-31. PubMed ID: 4354845
[No Abstract] [Full Text] [Related]
11. Pathophysiology of lipid transport disorders.
Levy RI
Postgrad Med J; 1975; 51(8):suppl 16-26. PubMed ID: 215978
[TBL] [Abstract][Full Text] [Related]
12. [Lipoprotein metabolism].
Corvilain B
Rev Med Brux; 1997 Feb; 18(1):3-9. PubMed ID: 9132915
[TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridaemia associated with an abnormal triglyceride-rich lipoprotein carrying excess apolipoprotein C-III-2.
Stocks J; Holdsworth G; Galton D
Lancet; 1979 Sep; 2(8144):667-71. PubMed ID: 90760
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
15. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
Hazzard WR; Bierman EL
Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hyperlipidemia.
Levy RI; Morganroth J; Rifkind BM
N Engl J Med; 1974 Jun; 290(23):1295-301. PubMed ID: 4363888
[No Abstract] [Full Text] [Related]
17. Modern management of hyperlipidemia.
Grundy SM
Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
[No Abstract] [Full Text] [Related]
18. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
[TBL] [Abstract][Full Text] [Related]
19. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
20. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
